Skip to main content
. Author manuscript; available in PMC: 2017 Sep 27.
Published in final edited form as: JAMA. 2016 Jun 14;315(22):2424–2434. doi: 10.1001/jama.2016.7602

Figure 3. Comparison of Weight Loss and Adverse Events With Pharmacological Weight Loss Agents in Network Meta-analysis.

Figure 3

Summary estimate represents odds ratio of achieving at least 5%weight loss (light gray background) and discontinuation due to adverse events (light blue background). Agents are ordered by rankings for the 5%weight loss outcome. Odds ratio for comparisons are in the cell in common between the column-defining and row-defining treatment. For weight loss outcome, row treatment is compared with column treatment (ie, column treatment is reference). For adverse event outcome, column treatment is compared with row treatment (ie, row treatment is reference). Numbers in parentheses indicate 95%credible intervals (95%CrIs). Numbers in bold represent statistically significant results.